先進創傷被覆材の世界市場分析および予測...市場調査レポートについてご紹介

1 Table of Contents
1 Table of Contents 5
1.1 List of Tables 13
1.2 List of Figures 18
2 Introduction 21
2.1 Catalyst 21
2.2 Related Reports 21
3 Industry Overview 22
3.1 Overview 22
3.2 Anatomy & Physiology 22
3.3 Indications 23
3.3.1 Acute Wounds 23
3.3.2 Chronic Wounds 24
3.3.3 Surgical Wounds 26
3.4 Clinical Outcomes 27
3.4.1 Normal Wound Healing Process 27
3.4.2 Key Factors to Wound Management 28
3.5 Applications of Technology 30
3.5.1 Traditional Wound Care Products 30
3.5.2 Current Advanced Wound Dressing Modalities 30
3.5.3 Biologics & Tissue-Engineered Products 34
3.5.4 Device and Equipment Therapies 34
3.6 Advantages and Disadvantages of Technology 35
3.7 Market Access 37
3.7.1 Overview 37
3.7.2 Adoption of Technology 37
3.7.3 Brand Loyalty and Relationships with Manufacturers 39
3.7.4 Purchasing Decisions 41
3.7.5 Influence of Clinical Trials 43
3.8 Regulatory Process 43
3.8.1 Overview 43
3.8.2 United States 44
3.8.3 Europe 45
3.8.4 Japan 46
3.8.5 China 46
3.8.6 India 47
3.8.7 Brazil 48
3.9 Reimbursement 49
3.9.1 Overview 49
3.9.2 United States 50
3.9.3 France 53
3.9.4 Germany 54
3.9.5 Italy 55
3.9.6 Spain 56
3.9.7 United Kingdom 56
3.9.8 Japan 57
3.9.9 China 58
3.9.10 India 59
3.9.11 Brazil 59
3.10 Industry Trends 60
3.10.1 Regulatory Issues & Recalls 60
3.10.2 Mergers, Acquisitions, and Key Partnerships 61
3.11 Economic Impact 63
3.11.1 Indirect Costs 63
3.11.2 Direct Costs 65
4 Unmet Needs 67
4.1 Overview 67
4.2 Optimal Antimicrobial Power 68
4.3 Enhancing Biologically Active Dressings 69
4.4 Minimizing Trauma and Pain at Wound Sites 70
4.5 Designing Multimodal Dressings 71
4.6 Advancing Indicators and Improving Diagnostic Power 71
4.7 Expanding Education and Awareness 72
5 Market Opportunity Analysis 75
5.1 Overview 75
5.2 Complementing Negative Pressure Wound Therapy 75
5.3 Engineering Dressings for Compression Therapy 76
5.4 Addressing Radiation Oncology Burns 76
5.5 Progressing Scar Management 77
5.6 Implementing Topical Drug Delivery 78
6 Market Drivers and Barriers 79
6.1 Drivers 79
6.1.1 Occurrence of Burns 79
6.1.2 Rising Rates of Diabetes 80
6.1.3 Aging Population 81
6.1.4 Rising Rates of Vascular Diseases 81
6.1.5 Rising Rates of Obesity 82
6.1.6 Need for Cost Savings 82
6.2 Barriers 83
6.2.1 Diminished Role of Advanced Dressings in Standard Therapies 83
6.2.2 Lack of Reimbursements 84
6.2.3 Complexities in Healthcare Systems 85
6.2.4 Regulatory Challenges 86
6.2.5 Lack of Clinical Data 87
6.2.6 Medical Device Excise Tax 88
6.2.7 Availability of Venture Capital 88
7 Competitive Assessment 89
7.1 Overview 89
7.2 Technology and Product Offerings 89
7.3 Product Profiles 90
7.3.1 Smith & Nephew 90
7.3.2 3M Health Care 95
7.3.3 Molnlycke Health Care 98
7.3.4 ConvaTec 101
7.3.5 Coloplast 104
7.3.6 Paul Hartmann 107
7.3.7 Systagenix Wound Management 110
7.3.8 Medline Industries 114
7.3.9 Laboratoires Urgo 117
7.3.10 BSN Medical 120
7.3.11 Covidien 123
7.3.12 B. Braun 126
7.3.13 Hollister 129
7.3.14 Derma Sciences 133
7.3.15 Lohmann & Rauscher 136
7.3.16 Advanced Medical Solutions 139
7.3.17 Nitto Denko 142
7.3.18 Winner Medical Group 142
7.3.19 DeRoyal Industries 144
7.3.20 Genewel 147
7.4 SWOT For Each Category 149
7.4.1 SWOT, Foams 149
7.4.2 SWOT, Hydrocolloids 149
7.4.3 SWOT, Semi-Permeable Films 150
7.4.4 SWOT, Hydrogels 150
7.4.5 SWOT, Alginates 151
7.4.6 SWOT, Hydrofibers 151
7.4.7 SWOT, Collagens 152
7.4.8 SWOT, Superabsorbents 152
7.4.9 SWOT, Wound Contact Layers 153
8 Pipeline Assessment 154
8.1 Overview 154
8.2 Product Profiles 154
8.2.1 MxBiodevices: Dermagrid 154
8.2.2 PolyNovo: NovoSorb BTM 155
8.2.3 Tissue Therapies: VitroGro ECM 156
8.2.4 Edixomed: ProNOx 157
8.2.5 KeraNetics: KeraStat 158
8.2.6 Arteriocyte: Magellan Bio-Bandage 159
8.2.7 Nanotherapeutics: NanoDOX 160
8.2.8 DeCell Technologies: DermGEN 161
8.2.9 Eqalix: OmegaSkin 162
9 Clinical Trials to Watch 163
9.1 Overview 163
9.2 Clinical Trial Profiles 163
9.2.1 Adocia 163
9.2.2 DermaPACE 163
9.2.3 Amnioexcel and DSC127 164
9.2.4 TransCu O2 165
9.2.5 Woundchek 165
10 Current and Future Players 167
10.1 Overview 167
10.2 Trends in Corporate Strategy 167
10.3 Company Profiles 168
10.3.1 Smith & Nephew 168
10.3.2 3M Health Care 170
10.3.3 Molnlycke Health Care 172
10.3.4 ConvaTec 174
10.3.5 Coloplast 176
10.3.6 Paul Hartmann 178
10.3.7 Systagenix Wound Management 179
10.3.8 Medline Industries 181
10.3.9 Laboratoires Urgo 183
10.3.10 BSN Medical 185
10.3.11 Covidien 186
10.3.12 B. Braun 188
10.3.13 Hollister 190
10.3.14 Derma Sciences 192
10.3.15 Lohmann & Rauscher 194
10.3.16 Advanced Medical Solutions Group 196
10.3.17 Nitto Denko 197
10.3.18 Winner Medical Group 199
10.3.19 Genewel 200
10.3.20 DeRoyal Industries 201
11 Strategic Competitive Assessment 203
11.1 Company Market Share 203
11.1.1 Global Overview 203
11.1.2 Company Share by Region 205
11.1.3 Company Share by Individual Country 207
12 Market Outlooks by Market Segment 217
12.1 Market Segment Share 217
12.1.1 Global 217
12.1.2 By Region 219
13 Market Outlooks by Geography 223
13.1 Global Overview 223
13.2 US 229
13.3 France 232
13.4 Germany 235
13.5 Italy 238
13.6 Spain 241
13.7 UK 244
13.8 Japan 247
13.9 China 250
13.10 India 253
13.11 Brazil 256
14 Appendix 259
14.1 Bibliography 259
14.2 Abbreviations 295
14.3 Report Methodology 298
14.3.1 Overview 298
14.3.2 Coverage 298
14.3.3 Secondary Research 299
14.4 Forecasting Methodology 300
14.5 Physicians and Specialists Included in This Study 301
14.5.1 Key Opinion Leaders 301
14.5.2 Primary Research Summary 302
14.6 About the Authors 303
14.6.2 Global Head of Healthcare 304
14.7 About GlobalData 305
14.8 Disclaimer 305